Eurofins Scientific SE (XPAR:ERF) Cash-to-Debt

: 0.31 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Eurofins Scientific SE's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.31.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Eurofins Scientific SE couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Eurofins Scientific SE's Cash-to-Debt or its related term are showing as below:

XPAR:ERF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08 Med: 0.3 Max: 0.6
Current: 0.31

During the past 13 years, Eurofins Scientific SE's highest Cash to Debt Ratio was 0.60. The lowest was 0.08. And the median was 0.30.

XPAR:ERF's Cash-to-Debt is ranked worse than
74.79% of 234 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.45 vs XPAR:ERF: 0.31

Eurofins Scientific SE Cash-to-Debt Historical Data

The historical data trend for Eurofins Scientific SE's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Eurofins Scientific SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.08

0.29

0.19

0.15

0.31

Eurofins Scientific SE Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.19	0.22	0.15	0.21	0.31

Competitive Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eurofins Scientific SE Cash-to-Debt Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Cash-to-Debt falls into.

Eurofins Scientific SE Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Eurofins Scientific SE's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1221.2	/	(601	+	3325.5)
	=	0.31

Eurofins Scientific SE's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1221.2	/	(601	+	3325.5)
	=	0.31

Eurofins Scientific SE (XPAR:ERF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Eurofins Scientific SE Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Eurofins Scientific SE (XPAR:ERF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (XPAR:ERF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

ERFSF:USA ERFp:UK 0MV5:UK ESF0:Germany

Address

23 Val Fleuri, Luxembourg, LUX, L-1526

Website

https://www.eurofins.com

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.